Matches in SemOpenAlex for { <https://semopenalex.org/work/W4287486587> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W4287486587 endingPage "13915" @default.
- W4287486587 startingPage "13909" @default.
- W4287486587 abstract "To determine the clinical efficacy and safety of urinary Kallindinogenase (HUK) combined with butylphthalide (NBP) in the treatment of progressive cerebral infarction (PCI), to provide more choices for the clinical treatment of PCI.The clinical data of 94 with PCI admitted to our hospital from July 2015 to March 2017 were retrospectively analyzed in this study. In addition to basic treatment, the control group (n = 52) was treated with NBP and edaravone. The research group (n = 42) was treated with NBP and HUK. After 14 days of treatment, the clinical efficacy on the two groups was evaluated according to their neurological function deficit using the National Institutes of Health Stroke Scale (NIHSS). The functional recovery results after the stroke were measured using the Modified Rankin Scale (MRS). The independence rate of the two groups was compared. The activities of daily living (ADL) scale was adopted to evaluate the patients' life quality. The two groups were compared in the incidence of complications during treatment and the recurrence within 12 months.The two groups of patients were not greatly different in basic data. After 14 days of treatment, the improvements in NIHSS, MRS, and ADL scores in the research group were more obvious than those in the control group. After 12 months of treatment, the research group showed a significantly higher independence rate than the control group. No serious adverse reactions were found in the two groups. There was no death during the treatment. After 12 months of treatment, the two groups were not greatly different in recurrence rate.HUK combined with NBP can reduce the neurological dysfunction and disability rate of patients and improve their independence rate and life quality. It is a safe and effective method for the treatment of PCI." @default.
- W4287486587 created "2022-07-25" @default.
- W4287486587 creator A5001235590 @default.
- W4287486587 date "2021-01-01" @default.
- W4287486587 modified "2023-09-29" @default.
- W4287486587 title "Clinical efficacy and safety of urinary kallindinogenase combined with butylphthalide in the treatment of progressive cerebral infarction." @default.
- W4287486587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35035732" @default.
- W4287486587 hasPublicationYear "2021" @default.
- W4287486587 type Work @default.
- W4287486587 citedByCount "1" @default.
- W4287486587 countsByYear W42874865872022 @default.
- W4287486587 crossrefType "journal-article" @default.
- W4287486587 hasAuthorship W4287486587A5001235590 @default.
- W4287486587 hasConcept C100480397 @default.
- W4287486587 hasConcept C120665830 @default.
- W4287486587 hasConcept C121332964 @default.
- W4287486587 hasConcept C126322002 @default.
- W4287486587 hasConcept C127413603 @default.
- W4287486587 hasConcept C159110408 @default.
- W4287486587 hasConcept C1862650 @default.
- W4287486587 hasConcept C2779450755 @default.
- W4287486587 hasConcept C2779554857 @default.
- W4287486587 hasConcept C2779951463 @default.
- W4287486587 hasConcept C2780645631 @default.
- W4287486587 hasConcept C2780931571 @default.
- W4287486587 hasConcept C2992053201 @default.
- W4287486587 hasConcept C3020199598 @default.
- W4287486587 hasConcept C42219234 @default.
- W4287486587 hasConcept C45393284 @default.
- W4287486587 hasConcept C500558357 @default.
- W4287486587 hasConcept C541997718 @default.
- W4287486587 hasConcept C61511704 @default.
- W4287486587 hasConcept C71924100 @default.
- W4287486587 hasConcept C77411442 @default.
- W4287486587 hasConcept C78519656 @default.
- W4287486587 hasConcept C79544238 @default.
- W4287486587 hasConceptScore W4287486587C100480397 @default.
- W4287486587 hasConceptScore W4287486587C120665830 @default.
- W4287486587 hasConceptScore W4287486587C121332964 @default.
- W4287486587 hasConceptScore W4287486587C126322002 @default.
- W4287486587 hasConceptScore W4287486587C127413603 @default.
- W4287486587 hasConceptScore W4287486587C159110408 @default.
- W4287486587 hasConceptScore W4287486587C1862650 @default.
- W4287486587 hasConceptScore W4287486587C2779450755 @default.
- W4287486587 hasConceptScore W4287486587C2779554857 @default.
- W4287486587 hasConceptScore W4287486587C2779951463 @default.
- W4287486587 hasConceptScore W4287486587C2780645631 @default.
- W4287486587 hasConceptScore W4287486587C2780931571 @default.
- W4287486587 hasConceptScore W4287486587C2992053201 @default.
- W4287486587 hasConceptScore W4287486587C3020199598 @default.
- W4287486587 hasConceptScore W4287486587C42219234 @default.
- W4287486587 hasConceptScore W4287486587C45393284 @default.
- W4287486587 hasConceptScore W4287486587C500558357 @default.
- W4287486587 hasConceptScore W4287486587C541997718 @default.
- W4287486587 hasConceptScore W4287486587C61511704 @default.
- W4287486587 hasConceptScore W4287486587C71924100 @default.
- W4287486587 hasConceptScore W4287486587C77411442 @default.
- W4287486587 hasConceptScore W4287486587C78519656 @default.
- W4287486587 hasConceptScore W4287486587C79544238 @default.
- W4287486587 hasIssue "12" @default.
- W4287486587 hasLocation W42874865871 @default.
- W4287486587 hasOpenAccess W4287486587 @default.
- W4287486587 hasPrimaryLocation W42874865871 @default.
- W4287486587 hasRelatedWork W12884417 @default.
- W4287486587 hasRelatedWork W14451903 @default.
- W4287486587 hasRelatedWork W15485086 @default.
- W4287486587 hasRelatedWork W3369567 @default.
- W4287486587 hasRelatedWork W3872747 @default.
- W4287486587 hasRelatedWork W3982033 @default.
- W4287486587 hasRelatedWork W6668834 @default.
- W4287486587 hasRelatedWork W6885004 @default.
- W4287486587 hasRelatedWork W765685 @default.
- W4287486587 hasRelatedWork W8485285 @default.
- W4287486587 hasVolume "13" @default.
- W4287486587 isParatext "false" @default.
- W4287486587 isRetracted "false" @default.
- W4287486587 workType "article" @default.